1. College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang Province, Zhejiang, People’s Republic of China
2. Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Zhejiang Province, People’s Republic of China
3. ;cCollaborative Innovation Center of Chinese Medicines from Zhejiang Province, Zhejiang Province, People’s Republic of China
4. ;dKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Hangzhou, Zhejiang Province, People's Republic of China
5. ;eHangzhou Huadong Medicine Group, Pharmaceutical Research Institute Co. Ltd, Hanzhou City, Zhejiang Province, People’s Republic of China
6. ;fINSERM, U1231, Label LipSTIC, and Ligue Nationale Contre Le Cancer, Dijon, France
7. ;gUniversité De Bourgogne-Franche Comté, I-SITE, France
8. ;hDepartment of Pharmacology-Toxicology & Metabolomics, University hospital of Besançon (CHU), 2 Boulevard Fleming, 25030 BESANCON, France
9. ;iAnti-cancer Center George-François Leclerc, CGFL, Dijon, France